CAN FITE BIOFARMA LTD (CANF)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
Institutions report 50,193 shares against 2,618,425 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end. Share count carried from an earlier filing (cy2025q4i).
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | $96.6K | 32,533 | 0.00% | 2q | -4.7%-$4.8K |
| RHUMBLINE ADVISERS | $51.8K | 17,433 | 0.00% | 2q | -16.6%-$10.3K |
| FIFTH THIRD BANCORP | $446 | 150 | 0.00% | 2q | HELD |
| WELLS FARGO & COMPANY/MN | $175 | 59 | 0.00% | 2q | -76.4% |
| Activest Wealth Management | $30 | 10 | 0.00% | 2q | HELD |
| TD Waterhouse Canada Inc. | $4 | 1 | 0.00% | 2q | HELD |
| MERCER GLOBAL ADVISORS INC /ADV | $3 | 1 | 0.00% | new | NEW |
| MORGAN STANLEY | $3 | 1 | 0.00% | 2q | HELD |
| Avion Wealth | $0 | 5 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 9 | $149.1K | 50,193 | 2 | 0 | 3 | 0.0% |
| Q1 2026 | 11 | $328.9K | 106,113 | 11 | 0 | 0 | 0.0% |
| Q4 2025 | 14 | $271.4K | 596,467 | 3 | 3 | 2 | 0.0% |
| Q3 2025 | 15 | $952.6K | 1,538,481 | 2 | 3 | 3 | 0.0% |
| Q2 2025 | 15 | $950.1K | 904,884 | 5 | 2 | 2 | 0.0% |
| Q1 2025 | 12 | $173.9K | 117,491 | 3 | 2 | 2 | 0.0% |
| Q4 2024 | 13 | $185.9K | 114,427 | 2 | 1 | 3 | 0.0% |
| Q3 2024 | 11 | $1.5M | 754,233 | 2 | 2 | 1 | 0.0% |
| Q2 2024 | 9 | $1.6M | 606,616 | 3 | 1 | 2 | 0.0% |
| Q1 2024 | 8 | $1.3M | 589,197 | 2 | 2 | 0 | 0.0% |
| Q4 2023 | 9 | $638.1K | 290,095 | 3 | 2 | 0 | 0.0% |
| Q3 2023 | 9 | $179.2K | 67,662 | 2 | 1 | 1 | 0.0% |
| Q2 2023 | 7 | $167.8K | 54,635 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 8 | $843.5K | 368,347 | 8 | 0 | 0 | 0.0% |
| Q4 2022 | 11 | $262.2K | 427,782 | 1 | 1 | 3 | 0.0% |
| Q3 2022 | 12 | $380.5K | 495,627 | 1 | 2 | 2 | 0.0% |
| Q2 2022 | 12 | $464.7K | 505,708 | 2 | 2 | 0 | 0.0% |
| Q1 2022 | 12 | $472.3K | 381,109 | 3 | 1 | 0 | 0.0% |
| Q4 2021 | 15 | $626.5K | 486,011 | 3 | 1 | 1 | 0.0% |
| Q3 2021 | 12 | $2.4M | 1,462,431 | 5 | 1 | 1 | 0.0% |
| Q2 2021 | 11 | $1.0M | 459,266 | 2 | 1 | 3 | 0.0% |
| Q1 2021 | 12 | $1.1M | 442,835 | 8 | 1 | 1 | 0.0% |
| Q4 2020 | 6 | $460.9K | 259,101 | 1 | 3 | 0 | 0.0% |
| Q3 2020 | 9 | $158.9K | 89,884 | 5 | 2 | 1 | 0.0% |
| Q2 2020 | 8 | $518.1K | 261,465 | 5 | 0 | 2 | 0.0% |
| Q1 2020 | 4 | $50.7K | 39,368 | 1 | 1 | 1 | 0.0% |
| Q4 2019 | 6 | $224.8K | 68,380 | 4 | 0 | 1 | 0.0% |
| Q3 2019 | 4 | $254.1K | 123,396 | 2 | 0 | 1 | 0.0% |
| Q2 2019 | 6 | $928.5K | 320,557 | 6 | 0 | 0 | 0.0% |
| Q1 2019 | 7 | $1.3M | 1,482,837 | 1 | 2 | 1 | 0.0% |
| Q4 2018 | 7 | $1.8M | 1,517,786 | 0 | 1 | 0 | 0.0% |